Immune Therapeutics Shareholders Summary

Immune Therapeutics released a shareholders update letter yesterday morning. This letter gives insight into what the company has been doing in the last year in regards to LDN. They have received approval from The NAFDAC in Africa fro HIV/AIDS and have receive distribution agreements to start treating patient. They have agreements in countries like Nigeria and Kenya and received a deposit from partner AHAR for LDN. Imun is always looking to add diseases to add to its approval list. They also will be adding to their board of directors to help increase the companies productivity and growth. Many amazing things are bound to come, all with hopes to help treat the worlds autoimmune, cancer, and overall health issue. Lets boost the worlds immune system and their confidence!